title: Association of pretreatment with antifungal medication and fungal resistance in the mycotic ulcer treatment trial I.
authors.affiliation: Aravind Eye Care System, Madurai, India.
authors.forename: N Venkatesh
authors.initials: NV
authors.lastname: Prajna
authors.affiliation: Aravind Eye Care System, Madurai, India.
authors.forename: Lalitha
authors.initials: L
authors.lastname: Prajna
authors.affiliation: Francis I. Proctor Foundation, University of California, San Francisco.
authors.forename: Kieran S
authors.initials: KS
authors.lastname: O'Brien
authors.affiliation: Francis I. Proctor Foundation, University of California, San Francisco.
authors.forename: Catherine Q
authors.initials: CQ
authors.lastname: Sun
authors.affiliation: Francis I. Proctor Foundation, University of California, San Francisco3Department of Epidemiology and Biostatistics, University of California, San Francisco4Department of Ophthalmology, University of California, San Francisco.
authors.forename: Nisha
authors.initials: N
authors.lastname: Acharya
authors.affiliation: Francis I. Proctor Foundation, University of California, San Francisco3Department of Epidemiology and Biostatistics, University of California, San Francisco4Department of Ophthalmology, University of California, San Francisco.
authors.forename: Thomas M
authors.initials: TM
authors.lastname: Lietman
authors.affiliation: Francis I. Proctor Foundation, University of California, San Francisco4Department of Ophthalmology, University of California, San Francisco5Department of Optometry, University of California, Berkeley.
authors.forename: Jennifer
authors.initials: J
authors.lastname: Rose-Nussbaumer
mesh_terms: D000284:Administration, Oral; D000287:Administration, Topical; D000328:Adult; D000935:Antifungal Agents / Q000627:therapeutic use*; D001228:Aspergillosis / Q000188:drug therapy* / Q000382:microbiology; D001232:Aspergillus fumigatus / Q000187:drug effects / Q000302:isolation & purification; D003320:Corneal Ulcer / Q000188:drug therapy* / Q000382:microbiology; D004311:Double-Blind Method; D025141:Drug Resistance, Fungal; D015821:Eye Infections, Fungal / Q000188:drug therapy* / Q000382:microbiology; D005260:Female; D060585:Fusariosis / Q000188:drug therapy* / Q000382:microbiology; D005670:Fusarium / Q000187:drug effects / Q000302:isolation & purification; D006801:Humans; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D010866:Natamycin / Q000627:therapeutic use; D065819:Voriconazole / Q000627:therapeutic use
chemical_list: D000935:Antifungal Agents; D010866:Natamycin; D065819:Voriconazole